Clearline Capital’s Allergan plc AGN Stock Holding History

Clearline Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-361,700	Closed	-$83.6M	–	64
2016 Q2	$83.6M	Buy	+361,700	New	+$83.4M	16.59%	1

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Clearline Capital's AGN Position: Q3 2018 in Review

Clearline Capital sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 25,335 shares — an estimated $4.22M sold.

Clearline Capital first reported a position in AGN in Q1 2014 and held it in 5 quarters. The position peaked at $48M in Q3 2016. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

Clearline Capital reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
Clearline Capital sold 25,335 Allergan plc shares in Q3 2018, an estimated $4.22M.
Clearline Capital first reported a position in Allergan plc in Q1 2014 and held it in 5 quarters.
Clearline Capital's Allergan plc position peaked at $48M in Q3 2016.
1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Clearline Capital's 13F filing for Q3 2018, filed 14 Nov 2018.